These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30096579)

  • 1. Effects of an education program on toileting behaviors and bladder symptoms in overactive bladder patients with type 2 diabetes: A randomized clinical trial.
    Xu D; Huang L; Gao J; Li J; Wang X; Wang K
    Int J Nurs Stud; 2018 Nov; 87():131-139. PubMed ID: 30096579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toileting behaviors and overactive bladder in patients with type 2 diabetes: a cross-sectional study in China.
    Xu D; Cheng R; Ma A; Zhao M; Wang K
    BMC Urol; 2017 Jun; 17(1):42. PubMed ID: 28610556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women With Overactive Bladder Exhibit More Unhealthy Toileting Behaviors: A Cross-sectional Study.
    Daily AM; Kowalik CG; Delpe SD; Kaufman MR; Dmochowski RR; Reynolds WS
    Urology; 2019 Dec; 134():97-102. PubMed ID: 31499079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among occupational stress, toileting behaviors, and overactive bladder in nurses: A multiple mediator model.
    Xu D; Zhu S; Li H; Gao J; Mou H; Wang K
    J Adv Nurs; 2019 Jun; 75(6):1263-1271. PubMed ID: 30585354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overactive bladder online self-management program with embedded avatars: a randomized controlled trial of efficacy.
    Andrade AD; Anam R; Karanam C; Downey P; Ruiz JG
    Urology; 2015 Mar; 85(3):561-7. PubMed ID: 25586473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of overactive bladder and its impact on quality of life in 1025 patients with type 2 diabetes in mainland China.
    Xu D; Gao J; Wang X; Huang L; Wang K
    J Diabetes Complications; 2017 Aug; 31(8):1254-1258. PubMed ID: 28533105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the bladder: poor sleep in women with overactive bladder syndrome.
    Savoie MB; Lee KA; Subak LL; Hernandez C; Schembri M; Fung CH; Grady D; Huang AJ
    Am J Obstet Gynecol; 2020 Jun; 222(6):600.e1-600.e13. PubMed ID: 31836545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: a path analysis.
    Xu D; Zhao M; Huang L; Wang K
    Health Qual Life Outcomes; 2018 Jan; 16(1):1. PubMed ID: 29291738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 3 Different Teaching Methods for a Behavioral Therapy Program for Female Overactive Bladder: A Randomized Controlled Trial.
    Gezginci E; Iyigun E; Yilmaz S
    J Wound Ostomy Continence Nurs; 2018; 45(1):68-74. PubMed ID: 29300292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
    Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
    J Urol; 2013 Jun; 189(6):2186-93. PubMed ID: 23246476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of acupuncture for elderly overactive bladder population in Hong Kong: study protocol for a randomized controlled trial.
    Chan YT; Zhang HW; Guo YQ; Chan TNH; Kwan YK; Lee CK; Ngan K; Lin ZX
    Trials; 2018 Jul; 19(1):376. PubMed ID: 30005707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study.
    Mattiasson A; Masala A; Morton R; Bolodeoku J;
    BJU Int; 2010 Apr; 105(8):1126-35. PubMed ID: 19818077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM; Macdiarmid SA; Wooldridge LS; Leong FC; Shobeiri SA; Rovner ES; Siegel SW; Tate SB; Jarnagin BK; Rosenblatt PL; Feagins BA
    J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
    Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
    Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.
    Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
    J Urol; 2017 Feb; 197(2S):S216-S223. PubMed ID: 28012773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study.
    Ozdedeli S; Karapolat H; Akkoc Y
    Clin Rehabil; 2010 Apr; 24(4):342-51. PubMed ID: 20212061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.